1. Signaling Pathways
  2. NF-κB
  3. NF-κB

NF-κB (核因子κB)

Nuclear factor-κB; Nuclear factor-kappaB

NF-κB(活化 B 细胞的核因子 κ 轻链增强子)是一种控制 DNA 转录的蛋白质复合物。NF-κB 存在于几乎所有动物细胞类型中,并参与细胞对压力、细胞因子、自由基、紫外线照射、氧化 LDL 以及细菌或病毒抗原等刺激的反应。NF-κB 在调节对感染的免疫反应中起着关键作用。NF-κB 的错误调节与癌症、炎症和自身免疫性疾病、感染性休克、病毒感染和免疫发育不当有关。NF-κB 还与突触可塑性和记忆过程有关。哺乳动物 NF-κB 家族中有五种蛋白质:NF-κB1、NF-κB2、RelA、RelB、c-Rel。

NF-κB (Nuclear factor kappa-light-chain-enhancer of activated B cells) is a protein complex that controls transcription of DNA. NF-κB is found in almost all animal cell types and is involved in cellular responses to stimuli such as stress, cytokines, free radicals, ultraviolet irradiation, oxidized LDL, and bacterial or viral antigens. NF-κB plays a key role in regulating the immune response to infection. Incorrect regulation of NF-κB has been linked to cancer, inflammatory, and autoimmune diseases, septic shock, viral infection, and improper immune development. NF-κB has also been implicated in processes of synaptic plasticity and memory. There are five proteins in the mammalian NF-κB family: NF-κB1, NF-κB2, RelA, RelB, c-Rel.

Cat. No. Product Name Effect Purity Chemical Structure
  • HY-117987
    CPS-11 Inhibitor 99.39%
    CPS-11 (N-(Hydroxymethyl)thalidomide) 是 Thalidomide (HY-14658) 类似物,是一种有效的抗癌剂 (anti-cancer agent)。CPS-11 可抑制 NF-κB,激活 NFAT,通过升高 ROS 抑制细胞因子表达。CPS-11 对 MM (多发性骨髓瘤)细胞系表现出更广泛的活性谱和更高的效力。
    CPS-11
  • HY-N4231
    Lucyoside B Inhibitor 99.21%
    Lucyoside B 在活化的巨噬细胞中通过 NF-κB 和激活因子蛋白-1途径抑制炎症介质的产生。
    Lucyoside B
  • HY-N6812
    Karacoline

    多根乌头碱

    99.55%
    Karacoline 是在植物 Aconitum kusnezoffii 中发现的二萜生物碱,能通过 NF-κB 信号通路减少椎间盘退变中细胞外基质的降解。
    Karacoline
  • HY-W100287
    Murrayafoline A Inhibitor 99.73%
    Murrayafoline A 是一种可从 Murraya tetramera 中提取的咔唑类生物碱。Murrayafoline A 通过直接靶向 Specificity protein 1 (Sp1),从而抑制 NF-κBMAPK 信号通路。Murrayafoline A 具有抗神经炎症活性。
    Murrayafoline A
  • HY-N1913A
    Danshensu sodium

    丹参素钠盐

    Inhibitor 98.00%
    Danshensu (Dan shen suan A) sodium 是一种具有口服活性的酚类化合物,可诱导 Nrf2/HO-1 激活并抑制 NF-κB 通路。Danshensu sodium 可减少活性氧 (ROS) 的产生,上调抗氧化防御机制并抑制内在的细胞凋亡途径。Danshensu sodium 对 SARS-CoV-2 显示出有效的抗病毒活性,EC50 为 0.97 μM。Danshensu sodium 具有抗氧化、抗凋亡、抗肺部炎症等作用,具有用于 COVID-19、心脑血管等疾病研究的潜力。
    Danshensu sodium
  • HY-137315
    TML-6 Inhibitor 99.01%
    TML-6 是一种口服有效的姜黄素衍生物,抑制 β-淀粉样前体蛋白和 β-淀粉样蛋白 () 的合成。TML-6 上调 Apo E,抑制 NF-κBmTOR,并增加抗氧化 Nrf2 基因的活性。TML-6 具有用于阿尔茨海默氏病 (AD) 研究的潜力。
    TML-6
  • HY-N6893
    Ergolide

    麦角内酯

    Inhibitor 99.75%
    Ergolide 是一种从欧亚旋覆花 (Inula Britannica) 的干燥花中分离出的倍半萜内酯。Ergolide 通过使 NF-κB 失活抑制 RAW 264.7 巨噬细胞中诱导的一氧化氮合酶和环加氧酶 2 的表达。
    Ergolide
  • HY-157793
    SMU-L11 Activator 99.64%
    SMU-L11 是一种特异性 TLR7 激动剂 (EC50=0.024 μM),可招募 MyD88 接头蛋白并激活下游 NF-κBMAPK 信号通路。SMU-L11 在小鼠模型中,显著增强免疫细胞活化并增强 CD4+ T 和 CD8+ T 细胞增殖,从而直接杀死肿瘤细胞并抑制肿瘤生长。SMU-L11 可用于癌症的研究,也有研究免疫系统疾病的潜力。
    SMU-L11
  • HY-119931
    2-Hydroxychalcone Inhibitor 98.80%
    2-hydroxychalcone 是一种天然黄酮,是一种抗氧化剂,抑制脂质过氧化。2-hydroxychalcone 通过下调 Bcl-2 诱导凋亡。2-Hydroxychalcone 可抑制NF-kB 的激活。
    2-Hydroxychalcone
  • HY-B1640R
    Ethacrynic acid (Standard) Inhibitor
    Ethacrynic acid (Standard) 是 Ethacrynic acid 的分析标准品。本产品用于研究及分析应用。Ethacrynic acid (Etacrynic acid) 是一种利尿剂。Ethacrynic acid 是谷胱甘肽 S-转移酶 (GSTs) 的抑制剂。Ethacrynic acid 是一种 NF-κB 信号传导途径的有效抑制剂,并且还调节白三烯的形成。Ethacrynic acid 还可抑制 L 型电压依赖性和储存操作的钙通道,从而导致气道平滑肌细胞松弛。Ethacrynic acid 具有抗炎特性,可减轻类维生素 A 诱导的小鼠耳部水肿。
    Ethacrynic acid (Standard)
  • HY-14928A
    Lobeglitazone sulfate Inhibitor 99.63%
    Lobeglitazone sulfate 是一种新型噻唑烷二酮。Lobeglitazone sulfate 是 PPAR 的激动剂,对 PPARγPPARα 的 EC50 为 137.4 nM 和 546.3 nM。Lobeglitazone sulfate 是 ERK/JNK/Smad/NF-κB 信号通路的抑制剂。Lobeglitazone sulfate 具有抗炎、抗糖尿病、抗纤维化和抗动脉粥样硬化的活性。
    Lobeglitazone sulfate
  • HY-W011849
    Phenyl β-D-glucopyranoside

    苯基-β-D-吡喃葡萄糖苷 水合物

    Inhibitor 99.85%
    Phenyl β-D-glucopyranoside 具有抗癌和抗炎活性。Phenyl β-D-glucopyranoside 抑制一氧化氮 (NO) 的产生以及 iNOSCOX-2 的表达。Phenyl β-D-glucopyranoside 还抑制 NF-κB 的核转位。
    Phenyl β-D-glucopyranoside
  • HY-B0185B
    Lidocaine hydrochloride hydrate

    盐酸利多卡因

    Inhibitor 99.90%
    Lidocaine (Lignocaine) hydrochloride hydrate 抑制涉及复杂电压和依赖性的钠通道 (sodium channels)。Lidocaine hydrochloride hydrate 通过调节 miR-145 表达和进一步抑制 MEK/ERKNF-κB 信号通路来减少胃癌细胞的生长,迁移和侵袭。Lidocaine hydrochloride hydrate 是一种酰胺衍生物,可用于研究室性心律失常。
    Lidocaine hydrochloride hydrate
  • HY-B1812
    Veratrole

    邻苯二甲醚

    Inhibitor 99.46%
    Veratrole 是一种广泛存在于植物中吸引传粉者的关键化合物。Veratrole 可用作一种安全的香料成分,急性毒性和给药毒性低。
    Veratrole
  • HY-112433A
    (S)-NIK SMI1 Control 99.28%
    (S)-NIK SMI1 是 NIK SMI1 (HY-112433) 的异构体,可作为实验中的对照化合物。NIK SMI1 是一种有效的选择性 NF-κB 诱导激酶 (NIK) 抑制剂,可抑制 NIK 催化的 ATP 水解为 ADP,IC50 为 0.23±0.17 nM。
    (S)-NIK SMI1
  • HY-134353B
    ADP-β-S trilithium Activator
    ADP-β-S trilithium 是 ADP-β-S (HY-134353) 的三锂盐形式。ADP-β-S trilithium 是 P2Y12 受体的激活剂,可上调小胶质细胞中的 IL-1β 和 IL-6 产生水平,促进 NF-κB 的磷酸化和核转位,并增强 NLRP3 炎症小体的活化。
    ADP-β-S trilithium
  • HY-P99635
    Gatralimab

    格曲利单抗

    Inhibitor
    Gatralimab (GZ-402668) 是一种 IgG1CD52 单克隆抗体。
    Gatralimab
  • HY-N2205
    Esculentoside H Inhibitor 98.73%
    Esculentoside H (EsH) 是从多年生植物 Phytolacca esculent 的根提取物中分离的一种皂苷。 Esculentoside H (EH) 具有抗肿瘤活性,其机制与 TNF 释放能力有关。 Esculentoside H (EsH) 通过阻断 JNK1/2 和 NF-κB 信号介导的基质金属蛋白酶-9 (MMP-9) 表达抑制结肠癌细胞迁移。
    Esculentoside H
  • HY-B0516
    Articaine hydrochloride

    盐酸阿替卡因

    Inhibitor 99.38%
    Articaine hydrochloride (Hoe-045) 是一种含酯基的酰胺类活性剂,可抑制或缓解疼痛,可逆地与神经内腔内电压门控钠通道的α亚基结合,能有效缓解疼痛。Articaine hydrochloride 通过抑制 NF-?B 的激活和 NLRP3 炎症小体通路改善脂多糖 (LPS) 诱导的急性肾损伤。
    Articaine hydrochloride
  • HY-N0492R
    α-Lipoic Acid (Standard)

    α-硫辛酸(标准品)

    Inhibitor 99.90%
    α-Lipoic Acid (Standard) 是 α-Lipoic Acid 的分析标准品。本产品用于研究及分析应用。α-Lipoic Acid (Thioctic acid) 是一种抗氧化剂,是线粒体酶复合物的重要辅助因子。α-Lipoic Acid 可抑制 NF-κB 依赖性的 HIV-1 LTR 活化。α-Lipoic Acid 诱导内质网应激 (ERS) 介导的肝癌细胞凋亡 (apoptosis)。α-Lipoic Acid 可与 CPUL1 (HY-151802) 合成自组装的纳米聚合体 CPUL1-LA NA,其抗肿瘤效果优于 CPUL1。
    α-Lipoic Acid (Standard)
目录号 产品名 / 同用名 应用 反应物种

NF-κB transcription factors are critical regulators of immunity, stress responses, apoptosis and differentiation. In mammals, there are five members of the transcription factor NF-κB family: RELA (p65), RELB and c-REL, and the precursor proteins NF-κB1 (p105) and NF-κB2 (p100), which are processed into p50 and p52, respectively. NF-κB transcription factors bind as dimers to κB sites in promoters and enhancers of a variety of genes and induce or repress transcription. NF-κB activation occurs via two major signaling pathways: the canonical and the non-canonical NF-κB signaling pathways[1]

 

The canonical NF-κB pathway is triggered by signals from a large variety of immune receptors, such as TNFR, TLR, and IL-1R, which activate TAK1. TAK1 then activates IκB kinase (IKK) complex, composed of catalytic (IKKα and IKKβ) and regulatory (NEMO) subunits, via phosphorylation of IKKβ. Upon stimulation, the IKK complex, largely through IKKβ, phosphorylates members of the inhibitor of κB (IκB) family, such as IκBα and the IκB-like molecule p105, which sequester NF-κB members in the cytoplasm. IκBα associates with dimers of p50 and members of the REL family (RELA or c-REL), whereas p105 associates with p50 or REL (RELA or c-REL). Upon phosphorylation by IKK, IκBα and p105 are degradated in the proteasome, resulting in the nuclear translocation of canonical NF-κB family members, which bind to specific DNA elements, in the form of various dimeric complexes, including RELA-p50, c-REL-p50, and p50-p50. Atypical, IKK-independent pathways of NF-κB induction also provide mechanisms to integrate parallel signaling pathways to increase NF-κB activity, such as hypoxia, UV and genotoxic stress.

 

The non-canonical NF-κB pathway is induced by certain TNF superfamily members, such as CD40L, BAFF and lymphotoxin-β (LT-β), which stimulates the recruitment of TRAF2, TRAF3, cIAP1/2 to the receptor complex. Activated cIAP mediates K48 ubiquitylation and proteasomal degradation of TRAF3, resulting in stabilization and accumulation of the NFκB-inducing kinase (NIK). NIK phosphorylates and activates IKKα, which in turn phosphorylates p100, triggering p100 processing, and leading to the generation of p52 and the nuclear translocation of p52 and RELB[2][3].

 

Reference:

[1]. Oeckinghaus A, et al. The NF-kappaB family of transcription factors and its regulation.Cold Spring Harb Perspect Biol. 2009 Oct;1(4):a000034. 
[2]. Taniguchi K, et al. NF-κB, inflammation, immunity and cancer: coming of age. Nat Rev Immunol. 2018 May;18(5):309-324.
[3]. Perkins ND,et al. Integrating cell-signalling pathways with NF-kappaB and IKK function. Nat Rev Mol Cell Biol. 2007 Jan;8(1):49-62.

Your Search Returned No Results.

Sorry. There is currently no product that acts on isoform together.

Please try each isoform separately.